エピソード

  • How Ophthalmology Strategics are Rewriting the Playbook

    How Ophthalmology Strategics are Rewriting the Playbook
    2026/04/29
    Ophthalmic executives discuss strategies to scale and grow in today’s economic and regulatory environments. Learn more about your ad choices. Visit megaphone.fm/adchoices
    続きを読む 一部表示
    6 分
  • Glaukos Issued J-Code for Recently Launched Epioxa

    Glaukos Issued J-Code for Recently Launched Epioxa
    2026/04/22
    Glaukos commercially launches its topical drug therapy for keratoconus; BVI’s next-generation phaco-vitrectomy surgical system receives CE Mark; and the ASCRS Executive Director recaps the 2nd annual Sightline meeting. Learn more about your ad choices. Visit megaphone.fm/adchoices
    続きを読む 一部表示
    5 分
  • Breaking News from the ASCRS Meeting in Washington DC

    Breaking News from the ASCRS Meeting in Washington DC
    2026/04/15
    Eyewire reports on new products and breaking news live from the American Society of Cataract and Refractive Surgery meeting in Washington DC. Learn more about your ad choices. Visit megaphone.fm/adchoices
    続きを読む 一部表示
    14 分
  • More than 3 Million Bottles of Eye Drops Recalled

    More than 3 Million Bottles of Eye Drops Recalled
    2026/04/08
    A major recall is announced for several store-brand OTC eye drops; the FDA extends dosing intervals for Eylea HD in patients with Wet AMD and DME; and Bausch + Lomb launches its second full range of vision IOL in Europe. Learn more about your ad choices. Visit megaphone.fm/adchoices
    続きを読む 一部表示
    5 分
  • Biogen Enters GA Treatment Market After Major Acquisition

    Biogen Enters GA Treatment Market After Major Acquisition
    2026/04/01
    Pharma giant Biogen announces its intention to acquire Apellis in a multi-billion dollar deal; a recently approved first-of-its-kind presbyopia drop is commercially launched; and Kodiak Sciences releases phase 3 data for its diabetic retinopathy drug candidate. Learn more about your ad choices. Visit megaphone.fm/adchoices
    続きを読む 一部表示
    6 分
  • Interview with ASCRS Executive Director Steve Speares

    Interview with ASCRS Executive Director Steve Speares
    2026/03/25
    The Executive Director of The American Society of Cataract & Refractive Surgery (ASCRS) previews the upcoming annual meeting and discusses the most pressing issues facing ophthalmology. Learn more about your ad choices. Visit megaphone.fm/adchoices
    続きを読む 一部表示
    12 分
  • Alcon and Lensar Call Off Merger

    Alcon and Lensar Call Off Merger
    2026/03/18
    Alcon and Lensar provide a major update to their proposed merger; the latest IOL on Johnson & Johnson’s Tecnis platform receives FDA approval; and the FDA issues another CRL to Aldeyra Therapeutics for its investigational dry eye drug reproxalap. Learn more about your ad choices. Visit megaphone.fm/adchoices
    続きを読む 一部表示
    6 分
  • FDA Agrees to Review Phentolamine for Presbyopia

    FDA Agrees to Review Phentolamine for Presbyopia
    2026/03/04
    The FDA agrees to review a presbyopia drop designed to modulate pupil dynamics; a new endocapsular device receives clearance in Europe; and Rayner makes an acquisition to expands its cataract surgery portfolio. Learn more about your ad choices. Visit megaphone.fm/adchoices
    続きを読む 一部表示
    12 分